Karanth S, McCann S M
Department of Physiology, University of Texas Southwestern Medical Center, Dallas 75235-9040.
Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2961-5. doi: 10.1073/pnas.88.7.2961.
Several monokines, proteins secreted by monocytes and macrophages, alter release of hormones from the anterior pituitary. We report here the ability of femtomolar concentrations of interleukin 2 (IL-2), a lymphokine released from T lymphocytes, to alter directly pituitary hormone release. The effects of concentrations of IL-2 ranging from 10(-17) to 10(-9) M on anterior pituitary hormone release were evaluated in vitro. Hemipituitaries were preincubated in 1 ml of Krebs-Ringer bicarbonate buffer (KRB) followed by incubation for 1 or 2 hr with KRB or KRB containing different concentrations of IL-2. This was followed by incubation for 30 min in 56 mM potassium medium to study the effect of pretreatment with IL-2 on subsequent depolarization-induced hormone release. Prolactin (PRL), luteinizing hormone (LH), follicle-stimulating hormone (FSH), corticotropin (ACTH), growth hormone (GH), and thyrotropic hormone (TSH) released into the incubation medium were measured by radioimmunoassay. IL-2 stimulated the basal release of PRL at 1 or 2 hr but suppressed the subsequent depolarization-induced PRL release, perhaps because the readily releasable pool of PRL was exhausted. The minimal effective dose (MED) was 10(-15) M. Conversely, IL-2 significantly suppressed the basal release of LH and FSH at 1 or 2 hr, with a MED of 10(-16) M, thus demonstrating a reciprocal action of the cytokine on lactotrophs and gonadotrophs. The subsequent depolarization-induced release of LH and FSH was suppressed, indicative of a persistent inhibitory action of IL-2. IL-2 stimulated ACTH and TSH release at 1 hr and the MEDs were 10(-12) and 10(-15) M, respectively. Conversely, IL-2 significantly lowered the basal release of GH at 1 hr, with a MED of 10(-15) M. The release of GH was not altered at 2 hr. The high potassium-induced release of ACTH, TSH, and GH was not affected. The results demonstrate that IL-2 at picomolar concentrations affects the release of anterior pituitary hormones. This cytokine may serve as an important messenger from lymphocytes exerting a direct paracrine action on the pituitary by its release from lymphocytes in the gland or concentrations in the blood that reach the gland may be sufficient to activate it.
几种单核因子,即由单核细胞和巨噬细胞分泌的蛋白质,可改变垂体前叶激素的释放。我们在此报告飞摩尔浓度的白细胞介素2(IL-2),一种从T淋巴细胞释放的淋巴因子,直接改变垂体激素释放的能力。在体外评估了浓度范围为10(-17)至10(-9)M的IL-2对垂体前叶激素释放的影响。将半垂体在1 ml Krebs-Ringer碳酸氢盐缓冲液(KRB)中预孵育,然后用KRB或含有不同浓度IL-2的KRB孵育1或2小时。随后在56 mM钾培养基中孵育30分钟,以研究用IL-2预处理对随后去极化诱导的激素释放的影响。通过放射免疫测定法测量释放到孵育培养基中的催乳素(PRL)、促黄体生成素(LH)、促卵泡激素(FSH)、促肾上腺皮质激素(ACTH)、生长激素(GH)和促甲状腺激素(TSH)。IL-2在1或2小时刺激PRL的基础释放,但抑制随后去极化诱导的PRL释放,这可能是因为易于释放的PRL池被耗尽。最小有效剂量(MED)为10(-15)M。相反,IL-2在1或2小时显著抑制LH和FSH的基础释放,MED为10(-16)M,从而证明细胞因子对催乳素细胞和促性腺激素细胞有相互作用。随后去极化诱导的LH和FSH释放受到抑制,表明IL-2具有持续的抑制作用。IL-2在1小时刺激ACTH和TSH释放,MED分别为10(-12)和10(-15)M。相反,IL-2在1小时显著降低GH的基础释放,MED为10(-15)M。2小时时GH的释放未改变。高钾诱导的ACTH、TSH和GH释放不受影响。结果表明,皮摩尔浓度的IL-2影响垂体前叶激素的释放。这种细胞因子可能作为淋巴细胞的重要信使,通过其在腺体内从淋巴细胞释放或血液中到达腺体的浓度足以激活它,从而对垂体发挥直接的旁分泌作用。